These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 30808819)
1. Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition. Katsuno Y; Meyer DS; Zhang Z; Shokat KM; Akhurst RJ; Miyazono K; Derynck R Sci Signal; 2019 Feb; 12(570):. PubMed ID: 30808819 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression. Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823 [TBL] [Abstract][Full Text] [Related]
3. B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells. Zhou H; Yu C; Kong L; Xu X; Yan J; Li Y; An T; Gong L; Gong Y; Zhu H; Zhang H; Yang X; Li Y Oncogene; 2019 May; 38(18):3371-3386. PubMed ID: 30635656 [TBL] [Abstract][Full Text] [Related]
4. Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells. Park SY; Kim MJ; Park SA; Kim JS; Min KN; Kim DK; Lim W; Nam JS; Sheen YY Oncotarget; 2015 Nov; 6(35):37526-43. PubMed ID: 26462028 [TBL] [Abstract][Full Text] [Related]
6. Structure Identification of ViceninII Extracted from Luo Y; Ren Z; Du B; Xing S; Huang S; Li Y; Lei Z; Li D; Chen H; Huang Y; Wei G Molecules; 2019 Jan; 24(1):. PubMed ID: 30609689 [TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells induce epithelial mesenchymal transition in melanoma by paracrine secretion of transforming growth factor-β. Lv C; Dai H; Sun M; Zhao H; Wu K; Zhu J; Wang Y; Cao X; Xia Z; Xue C Melanoma Res; 2017 Apr; 27(2):74-84. PubMed ID: 28079609 [TBL] [Abstract][Full Text] [Related]
8. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells. Cheng KY; Hao M Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743 [TBL] [Abstract][Full Text] [Related]
9. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer. Du B; Shim JS Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225 [TBL] [Abstract][Full Text] [Related]
10. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development. Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879 [TBL] [Abstract][Full Text] [Related]